DOI:
10.1055/s-00000076
Seminars in Speech and Language
LinksClose Window
References
Thurman AJ, Potter LA, Kim K. et al.
Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome.
J Neurodev Disord 2020;
12 (01) 12
We do not assume any responsibility for the contents of the web pages of other providers.